Market Indices
Sector Heatmap
MAZE — Maze Therapeutics, Inc. Common Stock
NasdaqMaze Therapeutics, Inc. Common Stock
- O
- 26.74
- H
- 26.91
- L
- 25.79
- V
- 624.92K
MAZE — Latest News & Headlines
20 StoriesMaze Therapeutics (MAZE) Shares Moved, So What Is Driving Attention Now? - Yahoo Finance
Maze Therapeutics (MAZE) Shares Moved, So What Is Driving Attention Now? Yahoo Finance
A kidney poster will share early research on reducing toxin uptake to limit injury - Stock Titan
A kidney poster will share early research on reducing toxin uptake to limit injury Stock Titan
Why is Maze Therapeutics stock climbing today? - Investing.com
Why is Maze Therapeutics stock climbing today? Investing.com
Maze Therapeutics (NasdaqGM:MAZE) Stock Forecast & Analyst Predictions - Simply Wall Street
Maze Therapeutics (NasdaqGM:MAZE) Stock Forecast & Analyst Predictions Simply Wall Street
3 Small-Cap Stocks With Catalysts That Could Put Them in the Spotlight - MarketBeat
3 Small-Cap Stocks With Catalysts That Could Put Them in the Spotlight MarketBeat
Stock Market Split As Nasdaq Hits High, Dow Jones Slides Amid Surging Treasury Yields: Weekly Review - Investor's Business Daily
Stock Market Split As Nasdaq Hits High, Dow Jones Slides Amid Surging Treasury Yields: Weekly Review Investor's Business Daily
Why (MAZE) Price Action Is Critical for Tactical Trading - Stock Traders Daily
Why (MAZE) Price Action Is Critical for Tactical Trading Stock Traders Daily
Maze Therapeutics Shares Rise 2.9% After CIBC Initiates Coverage - Yahoo Finance
Maze Therapeutics Shares Rise 2.9% After CIBC Initiates Coverage Yahoo Finance
An officer plans to sell 16,141 Maze Therapeutics (MAZE) shares on October 1, 2026. - Stock Titan
An officer plans to sell 16,141 Maze Therapeutics (MAZE) shares on October 1, 2026. Stock Titan
Maze Therapeutics (MAZE) Valuation Turns On Early Pipeline Data Following A Recent Share Price Bounce - Simply Wall Street
Maze Therapeutics (MAZE) Valuation Turns On Early Pipeline Data Following A Recent Share Price Bounce Simply Wall Street
BTIG Initiates Maze Therapeutics at Buy With $50 Price Target - Yahoo Finance
BTIG Initiates Maze Therapeutics at Buy With $50 Price Target Yahoo Finance
An officer proposes selling 34,501 shares held by two trusts at Maze Therapeutics (Nasdaq: MAZE). - Stock Titan
An officer proposes selling 34,501 shares held by two trusts at Maze Therapeutics (Nasdaq: MAZE). Stock Titan
After exercising options, Harold Bernstein sold 16,141 Maze Therapeutics (MAZE) shares. - Stock Titan
After exercising options, Harold Bernstein sold 16,141 Maze Therapeutics (MAZE) shares. Stock Titan
Could Vertex Pharmaceuticals (VRTX)’s Kidney Breakthrough Unlock a New Opportunity for Maze Therapeutics (MAZE)? - Yahoo Finance
Could Vertex Pharmaceuticals (VRTX)’s Kidney Breakthrough Unlock a New Opportunity for Maze Therapeutics (MAZE)? Yahoo Finance
7,500 shares sold under a trading plan at Maze Therapeutics (MAZE) after an option exercise. - Stock Titan
7,500 shares sold under a trading plan at Maze Therapeutics (MAZE) after an option exercise. Stock Titan
Dianthus Therapeutics, Inc. (DNTH) Stock Price, News, Quote & History - Yahoo! Finance Canada
Dianthus Therapeutics, Inc. (DNTH) Stock Price, News, Quote & History Yahoo! Finance Canada
Two trusts sold 31,908 and 2,593 shares under Maze Therapeutics (MAZE) CEO Jason V. Coloma’s trading plan. - Stock Titan
Two trusts sold 31,908 and 2,593 shares under Maze Therapeutics (MAZE) CEO Jason V. Coloma’s trading plan. Stock Titan
SEC Filings for Oct 2, 2026 - 10-K, 10-Q, 8-K Forms - Stock Titan
SEC Filings for Oct 2, 2026 - 10-K, 10-Q, 8-K Forms Stock Titan
2026 IPO stock tracker: How newly public biotechs are performing - BioSpace
2026 IPO stock tracker: How newly public biotechs are performing BioSpace
McDonald's Is Undergoing a Massive New Growth Strategy. Can It Win Back Consumers? - TradingView
McDonald's Is Undergoing a Massive New Growth Strategy. Can It Win Back Consumers? TradingView